List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 44 studies with search of:   "Ascites"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
Conditions: Ascites;   Liver Cirrhosis
Interventions: Drug: satavaptan (SR121463B);   Drug: placebo
2 Completed Satavaptan Dose-Ranging Study in the Prevention of Ascites
Conditions: Ascites;   Liver Cirrhosis
Intervention: Drug: satavaptan (SR121463B)
3 Terminated Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
Conditions: Ascites;   Liver Cirrhosis
Interventions: Drug: satavaptan (SR121463B);   Drug: placebo
4 Active, not recruiting Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver (SPARe-2)
Conditions: Ascites;   Liver Cirrhosis
Interventions: Drug: satavaptan (SR121463B);   Drug: placebo
5 Recruiting Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Conditions: Ovarian Neoplasms;   Ascites
Intervention: Drug: catumaxomab
6 Recruiting Trial of Sunitinib for Refractory Malignant Ascites
Condition: Ascites
Intervention: Drug: Sunitinib
7 Recruiting Sodium Restriction in the Management of Cirrhotic Ascites
Condition: Ascites
Interventions: Other: Sodium restriction;   Other: Sodium restriction
8 Completed Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
Conditions: Ascites;   Liver Cirrhosis
Intervention: Drug: satavaptan (SR121463B)
9 Completed Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites
Conditions: Ascites;   Liver Cirrhosis
Intervention: Drug: satavaptan (SR121463B)
10 Active, not recruiting Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites
Conditions: Ovarian Neoplasms;   Ascites
Interventions: Drug: aflibercept (AVE0005 / VEGF Trap);   Drug: placebo
11 Completed North American Study for the Treatment of Refractory Ascites (NASTRA)
Conditions: Ascites;   Liver Cirrhosis
Interventions: Procedure: Transjugular intrahepatic portasystemic shunts (TIPS);   Procedure: Total paracentecis (TP)
12 Not yet recruiting Adrenal Insufficiency in Cirrhotics With Ascites. Effects of Hydrocortisone on Renal and Haemodynamic Function
Condition: Cirrhosis With Ascites
Interventions: Drug: hydrocortisone;   Drug: dextrose solution 5%
13 Completed Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)
Conditions: Cirrhosis;   Ascites
Interventions: Drug: Spironolactone and furosemide;   Drug: Spironolactone and furosemide
14 Recruiting Prevention of Decompensation in Liver Cirrhosis
Conditions: Alcoholic Liver Cirrhosis;   Ascites
Intervention: Drug: losartan (drug)
15 Suspended Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
Conditions: Cirrhosis;   Ascites
Interventions: Drug: 20% Human Albumin;   Drug: Normal Saline
16 Completed The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
Conditions: Type 2 Hepatorenal Syndrome;   Refractory Ascites
Interventions: Drug: Midodrine, albumin, octreotide LAR;   Drug: midodrine, octreotide, albumin
17 Recruiting Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction
Condition: Tense Ascites in Cirrhosis
Interventions: Drug: albumin 4 gr/L ascites removed;   Drug: albumin 8 gr/L ascites removed
18 Completed Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites
Conditions: Cirrhosis;   Ascites
Intervention: Drug: Terlipressin
19 Recruiting Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients
Conditions: Cirrhosis;   Ascites;   Infections
Interventions: Drug: Ciprofloxacin;   Drug: Placebo
20 Recruiting Vasoconstrictors as Alternatives to Albumin After LVP (Large-Volume Paracentesis) in Cirrhosis
Conditions: Ascites;   Cirrhosis
Interventions: Drug: albumin;   Drug: octreotide plus midodrine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services